Clinical trial · Observational
Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer
Human Papillomavirus (HPV) Type Distribution in Adult African Women Diagnosed With Invasive Cervical Cancer
NCT01207999CI-TRIAL-00008535completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to assess the distribution of the most frequent types of human papillomavirus in African women diagnosed with invasive cervical cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Infections, Papillomavirus | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Collection of cervical cancer tissue samples | Procedure | — | UNRESOLVED |
| Data collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Group A
- description
- Subjects diagnosed with invasive cervical cancer
- interventionNames
- Procedure: Collection of cervical cancer tissue samples
- Other: Data collection
Primary outcomes (2)
- measure
- Occurrence of any of the human papillomavirus types (HPV-16, 18, 31, 33, 35, 45, 52 and 58) among the women diagnosed with invasive cervical cancer
- timeFrame
- Average time frame: 6-12 months
- measure
- Occurrence of any of the human papillomavirus types (human papillomavirus-16, 18, 31, 33, 35, 45, 52 and 58) among the women diagnosed with squamous cell carcinoma
- timeFrame
- Average time frame: 6-12 months
Secondary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * A female aged 21 years or more, presenting with a lesion macroscopically suggestive of invasive cervical cancer. * Scheduled for cervical biopsy as per routine procedure at the participating institution on the day of the visit or on a later date. * Written or oral-witnessed informed consent obtained from the subject prior to any study procedure. * No prior chemo- or radiotherapy for cervical cancer. Exclusion Criteria: Not applicable
References
Publications (0)
Data not yet available
No reference posted for this study.